Skip to main content
. 2020 May-Jun;35(3):274–284. doi: 10.21470/1678-9741-2018-0362

Table 4.

Perioperative and early postoperative characteristics of the patients stratified by NLR quartiles.

Characteristics Overall Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-value
n=751 n=189 n=188 n=187 n=187
  0.17-1.83 1.84-2.47 2.48-3.23 ≥ 3.24
Operative data
    Number of distal anastomoses 3.41±0.88 3.40±0.86 3.29±0.86 3.48±0.88 3.47±0.92 0.24
    Incomplete revascularization 136 (18.1) 31 (16.4) 38 (20.2) 34 (18.2) 33 (17.6) 0.81
    Number of grafted LAD 1.65±0.55 1.66±0.5 1.63±0.58 1.65±0.56 1.67±0.56 0.48
    Number of grafted Cx 0.99±0.65 0.97±0.57 0.96±0.67 1±0.69 1.03±0.65 0.64
    Number of grafted RCA 0.75±0.53 0.75±0.54 0.68±0.5 0.8±0.56 0.76±0.51 0.23
    Endarterectomy 69 (9.2) 20 (10.6) 15 (8) 18 (9.6) 16 (8.6) 0.82
    CPB time 87.83±26.5 87.45±26.68 85.92±30.57 85.1±21.55 94.52±26.47 0.76
Postoperative data
    Hospital stay (days) 5.84±2.71 5.70±1.59 5.83±2.79 5.62±1.94 6.22±3.91 0.21
    Prolonged mechanical ventilation time 19 (2.5) 2 (1.1) 3 (1.6) 4 (2.1) 10 (5.3) 0.038*
    Intensive care unit stay (h) 22.8±45.81 19.15±6.45 22.02±25.25 20.55±16.79 29.54±86.21 0.007*
    Drainage (ml/24 h) 511.63±298.83 508.65±304.34 500±252.55 496.9±308.31 544.71±330.99 0.7
    Blood transfusion (unit) 1.35±1.54 1.24±1.39 1.23±1.58 1.25±1.42 1.69±1.71 0.002*
    cTnI (ng/ml) 2.48±2.99 2.02±2.13 2.33±2.92 2.6±3.52 2.89±3.16 0.09
    Perioperative inotropic support 42 (5.6) 7 (3.7) 9 (4.8) 8 (4.3) 18 (9.6) 0.048*
    Perioperative IABP 7 (0.9) 1 (0.5) 2 (1.1) 1 (0.5) 3 (1.6) 0.65
    Perioperative NSTEMI 62 (8.3) 20 (10.6) 14 (7.4) 15 (8) 16 (8.6) 0.72
    Early STEMI (<30 days) 6 1 (0.5) 0 1 (0.5) 4 (2.1) 0.1
    Perioperative AF 94 (12.5) 16 (8.5) 27 (14.4) 24 (12.8) 27 (14.4) 0.25
    Perioperative renal failure 103 (13.7) 25 (13.2) 20 (10.6) 29 (15.5) 29 (15.5) 0.46
    Pulmonary complication 21 (2.8) 4 (2.1) 6 (3.1) 3 (1.6) 8 (4.3) 0.4
    Reintubation/NIMV 11 (1.4) 1 (0.5) 3 (1.6) 0 7 (3.7) 0.013*
    Neurological complication 52 (6.9) 14 (7.4) 9 (8.4) 13 (7) 16 (8.4) 0.53
    Encephalopathy 22 (2.9) 4 (2.1) 6 (3.2) 4 (2.1) 8 (4.3) 0.55
    TIA 28 (3.7) 11 (5.8) 3 (1.6) 8 (4.3) 6 (3.2) 0.17
    Stroke 5 (0.7) 0 0 1 (0.5) 4 (2.1) 0.034*
    Mediastinitis 5 (0.7) 1 (0.5) 0 2 (1.1) 2 (1.1) 0.16
    Early reoperation 12 (2.3) 4 (2.1) 3 (1.6) 2 (1.1) 3 (1.6) 0.49
    Early reoperation due to bleeding 10 (1.3) 3 (1.6) 3 (1.6) 2 (1.1) 2 (1.1) 0.94
    Early rehospitalisation (<30 days) 48 (6.4) 15 (7.9) 6 (3.2) 14 (7.5) 13 (7) 0.06
    Mortality (<30 days)   8 (1.1) 1 (0.5) 1 (0.5) 0 6 (3.2) 0.011*
    MACCE (<30 days) 19 (2.5) 4 (2.1) 2 (1.1) 4 (2.1) 9 (4.8) 0.12
*

Statistically significant difference. Values are presented as mean ± standard deviation or number (%), where appropriate. AF=atrial fibrillation; CPB=cardiopulmonary bypass; Cx=circumflex coronary artery; cTnI=cardiac troponin I; FFP=fresh frozen plasma; IABP=intra-aortic balloon pump; LAD=left anterior descending coronary artery; LIMA=left internal mammary artery; MACCE=major adverse cardiac and cerebrovascular event; MI=myocardial infarction; NIMV=non-invasive mechanical ventilation; NSTEMI=non-ST elevation myocardial infarction; RCA=right coronary artery; STEMI= ST elevation myocardial infarction; TIA=transient ischemic attack